Lineage Cell Therapeutics (LCTX) Deferred Taxes (2013 - 2023)
Lineage Cell Therapeutics (LCTX) posted quarterly Deferred Taxes of -$1.8 million for Q1 2023, down 77.87% quarter-over-quarter from -$1.0 million in Q3 2021.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Deferred Taxes (2013 - 2023) Analysis & Trends
Lineage Cell Therapeutics' Deferred Taxes history runs 8 years deep, the most recent figure standing at -$1.8 million for Q1 2023.
- In Q1 2023, Deferred Taxes changed N/A year-over-year to -$1.8 million; the TTM figure through Dec 2023 stood at -$1.8 million (changed N/A YoY), while the FY2025 annual figure was -$5.3 million, changed N/A from the prior year.
- Deferred Taxes for Q1 2023 stood at -$1.8 million, down from -$1.0 million in the prior quarter.
- The five-year high for Deferred Taxes was $6.7 million in Q4 2019, with the low at -$4.4 million in Q1 2019.
- The 4-year median for Deferred Taxes is -$1.0 million (2021), against an average of -$467888.9.
- The sharpest annual moves came in 2020 and 2021: Deferred Taxes soared 79.82% in 2020, then plunged 406.0% in 2021.
- Lineage Cell Therapeutics' Deferred Taxes stood at $6.7 million in 2019, then sank by 115.95% to -$1.1 million in 2020, then rose by 4.62% to -$1.0 million in 2021, then slumped by 77.87% to -$1.8 million in 2023.
- Business Quant data shows LCTX's Deferred Taxes at -$1.8 million in Q1 2023, -$1.0 million in Q3 2021, and -$169000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Lineage Cell Therapeutics | 270.71 Mn | 213.99 Mn | 1.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | -1.80 Mn |
| Sep 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | -169,000.00 |
| Dec 31, 2020 | -1.04 Mn |
| Sep 30, 2020 | -200,000.00 |
| Dec 31, 2019 | 6.65 Mn |
| Sep 30, 2019 | -991,000.00 |
| Jun 30, 2019 | -1.25 Mn |
| Mar 31, 2019 | -4.38 Mn |
| Dec 31, 2017 | -5.00 Mn |
| Sep 30, 2017 | 4.77 Mn |
| Mar 31, 2017 | 3.88 Mn |
| Dec 31, 2015 | -1.12 Mn |
| Sep 30, 2015 | -948,000.00 |
| Jun 30, 2015 | -1.27 Mn |
| Mar 31, 2015 | -1.18 Mn |
| Dec 31, 2014 | -2.20 Mn |
| Sep 30, 2014 | -2.31 Mn |
| Jun 30, 2014 | -1.51 Mn |